EAACI Congress 2024

Back

31 May - 03 June 2024 Valencia, Spain

MSAT1-1 - Takeda – HAE and pregnancy: navigating the challenges

Friday 31 May, 17:00 PM - 17:30 PM Valencia, Spain

Alicante Channel Alicante Sponsored Sessions Access On Demand Section

Review World Allergy Organization (WAO)/EAACI guideline recommendations for the broad use of plasma-derived C1 esterase inhibitor (pdC1-INH) in hereditary angioedema (HAE)
Evaluate treatment data for pregnant and breastfeeding patients with HAE
Illustrate real-world challenges and considerations for managing pregnant and breastfeeding patients with HAE

17:00

Welcome and introduction

17:03

Balancing HAE and pregnancy: treatment recommendations and approaches

17:13

From theory to practice: managing HAE and pregnancy

17:21

Expert discussion and Q&A